Management and Treatment of Atopic Dermatitis in Primary Care
DOI:
https://doi.org/10.58931/cpct.2023.116Abstract
Atopic dermatitis (AD) is a chronic, relapsing, and remitting, inflammatory skin disease characterized by erythema, edema, xerosis, erosions/excoriations, oozing and crusting. It typically begins in childhood and often in infancy. The disease can wax and wane and for many patients it becomes less severe or even remits over time. Seasonal variation is common, with most patients experiencing a worsening of symptoms in the wintertime, particularly in Canada.
References
Gooderham MJ, Bissonnette R, Grewal P, Lansang P, Papp KA, Hong CH. Approach to the assessment and management of adult patients with atopic dermatitis: a consensus document. Section II: tools for assessing the severity of atopic dermatitis. J Cutan Med Surg. 2018 Nov;22(1_suppl):10S-6S. DOI: https://doi.org/10.1177/1203475418803628
Asher MI, Rutter CE, Bissell K, Chiang CY, El Sony A, Ellwood E, Ellwood P, García-Marcos L, Marks GB, Morales E, Mortimer K. Worldwide trends in the burden of asthma symptoms in school-aged children: Global Asthma Network Phase I Cross-sectional study. Lancet. 2021 Oct 30;398(10311):1569-80.
Weiss ST. Eat dirt—the hygiene hypothesis and allergic diseases. N Engl J Med. 2002 Sep 19;347(12):930-1. DOI: https://doi.org/10.1056/NEJMe020092
Hill DA, Spergel JM. The atopic march: critical evidence and clinical relevance. Ann Allergy Asthma Immunol. 2018 Feb 1;120(2):131-7. DOI: https://doi.org/10.1016/j.anai.2017.10.037
Kirchhof MG, Landells I, Lynde CW, Gooderham MJ, Hong CH. Approach to the assessment and management of adult patients with atopic dermatitis: a consensus document. Section I: pathophysiology of atopic dermatitis and implications for systemic therapy. J Cutan Med Surg. 2018 Nov;22(1_suppl):6S-9S. DOI: https://doi.org/10.1177/1203475418803626
Eichenfield LF, et al. Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis. J Am Acad Dermatol. 2014;70(2):338-51. DOI: https://doi.org/10.1016/j.jaad.2013.10.010
Eichenfield LF, Hanifin JM, Luger TA, Stevens SR, Pride HB. Consensus conference on pediatric atopic dermatitis. J Am Acad Dermatol. 2003 Dec 1;49(6):1088-95. DOI: https://doi.org/10.1016/S0190-9622(03)02539-8
Gooderham M, Lynde CW, Papp K, Bourcier M, Guenther L, Gulliver W, Hong CH, Poulin Y, Sussman G, Vender R. Review of systemic treatment options for adult atopic dermatitis. J Cutan Med Surg. 2017 Jan;21(1):31-9. DOI: https://doi.org/10.1177/1203475416670364
Gabros S, Nessel TA, Zito PM. Topical corticosteroids. StatPearls Publishing; 2018.
Faergemann J, Christensen O, Sjövall P, Johnsson A, Hersle K, Nordin P, Edmar B, Svensson Å. An open study of efficacy and safety of long‐term treatment with mometasone furoate fatty cream in the treatment of adult patients with atopic dermatitis. J Eur Acad Dermatol Venereol. 2000 Sep;14(5):393-6. DOI: https://doi.org/10.1046/j.1468-3083.2000.00099.x
Wollenberg A, Reitamo S, Atzori F, Lahfa M, Ruzicka T, Healy E, Giannetti A, Bieber T, Vyas J, Deleuran M, European Tacrolimus Ointment Study Group. Proactive treatment of atopic dermatitis in adults with 0.1% tacrolimus ointment. Allergy. 2008 Jun;63(6):742-50. DOI: https://doi.org/10.1111/j.1398-9995.2007.01406.x-i1
Weidinger S, Baurecht H, Schmitt J. A 5‐year randomized trial on the safety and efficacy of pimecrolimus in atopic dermatitis: a critical appraisal. Br J Dermatol. 2017; 177(4):999-1003. DOI: https://doi.org/10.1111/bjd.15827
Arcutis Biotherapeutics, Inc. Arcutis announces positive topline results from INTEGUMENT-1 pivotal Phase 3 trial of Roflumilast cream in atopic dermatitis in adults and children aged six years and older. Globe Newswire. 2022 Nov 15. https://www.arcutis.com/arcutis-announces-positive-topline-results-from-integument-1-pivotal-phase-3-trial-of-roflumilast-cream-in-atopic-dermatitis-in-adults-and-children-aged-six-years-and-older.
Peppers J, Paller AS, Maeda-Chubachi T, Wu S, Robbins K, Gallagher K, Kraus JE. A phase 2, randomized dose-finding study of tapinarof (GSK2894512 cream) for the treatment of atopic dermatitis. J Am Acad Dermatol. 2019 Jan 1;80(1):89-98. DOI: https://doi.org/10.1016/j.jaad.2018.06.047
Hong CH, Gooderham MJ, Albrecht L, et al. Approach to the assessment and management of adult patients with atopic dermatitis: a consensus document. Section V: consensus statements on the assessment and management of adult patients with moderate-to-severe atopic dermatitis. J Cutan Med Surg. 2018;22(1_suppl):30S-35S. DOI: https://doi.org/10.1177/1203475418803625
Published
Versions
- 2023-03-28 (2)
- 2023-03-28 (1)
How to Cite
Issue
Section
License
Copyright (c) 2023 Canadian Primary Care Today
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
